β-adrenergic induction of lipolysis in hepatocytes is inhibited by ethanol exposure

Micah B. Schott, Karuna Rasineni, Shaun G. Weller, Ryan J. Schulze, Arthur C. Sletten, Carol A Casey, Mark A. McNiven

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

In liver steatosis (i.e. fatty liver), hepatocytes accumulate many large neutral lipid storage organelles known as lipid droplets (LDs). LDs are important in the maintenance of energy homeostasis, but the signaling mechanisms that stimulate LD metabolism in hepatocytes are poorly defined. In adipocytes, catecholamines target the β-adrenergic (β-AR)/cAMP pathway to activate cytosolic lipases and induce their recruitment to the LD surface. Therefore, the goal of this study was to determine whether hepatocytes, like adipocytes, also undergo cAMP-mediated lipolysis in response to β-AR stimulation. Using primary rat hepatocytes and human hepatoma cells, we found that treatment with the β-AR agent isoproterenol caused substantial LD loss via activation of cytosolic lipases adipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL). β-Adrenergic stimulation rapidly activated PKA, which led to the phosphorylation of ATGL and HSL and their recruitment to the LD surface. To test whether this β-AR-dependent lipolysis pathway was altered in a model of alcoholic fatty liver, primary hepatocytes from rats fed a 6-week EtOH-containing Lieber-DeCarli diet were treated with cAMP agonists. Compared with controls, EtOH-exposed hepatocytes showed a drastic inhibition in β-AR/cAMP-induced LD breakdown and the phosphorylation of PKA substrates, including HSL. This observation was supported in VA-13 cells, an EtOH-metabolizing human hepatoma cell line, which displayed marked defects in bothPKAactivation and isoproterenol-induced ATGL translocation to the LD periphery. In summary, these findings suggest that β-AR stimulation mobilizes cytosolic lipases for LD breakdown in hepatocytes, and perturbation of this pathway could be a major consequence of chronic EtOH insult leading to fatty liver.

Original languageEnglish (US)
Pages (from-to)11815-11828
Number of pages14
JournalJournal of Biological Chemistry
Volume292
Issue number28
DOIs
StatePublished - Jul 14 2017

Fingerprint

Lipolysis
Adrenergic Agents
Hepatocytes
Ethanol
Lipase
Lipids
Sterol Esterase
Liver
Fatty Liver
Phosphorylation
Isoproterenol
Adipocytes
Hepatocellular Carcinoma
Rats
Alcoholic Fatty Liver
Lipid Droplets
Lipid Metabolism
Organelles
Nutrition
Catecholamines

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Schott, M. B., Rasineni, K., Weller, S. G., Schulze, R. J., Sletten, A. C., Casey, C. A., & McNiven, M. A. (2017). β-adrenergic induction of lipolysis in hepatocytes is inhibited by ethanol exposure. Journal of Biological Chemistry, 292(28), 11815-11828. https://doi.org/10.1074/jbc.M117.777748

β-adrenergic induction of lipolysis in hepatocytes is inhibited by ethanol exposure. / Schott, Micah B.; Rasineni, Karuna; Weller, Shaun G.; Schulze, Ryan J.; Sletten, Arthur C.; Casey, Carol A; McNiven, Mark A.

In: Journal of Biological Chemistry, Vol. 292, No. 28, 14.07.2017, p. 11815-11828.

Research output: Contribution to journalArticle

Schott, MB, Rasineni, K, Weller, SG, Schulze, RJ, Sletten, AC, Casey, CA & McNiven, MA 2017, 'β-adrenergic induction of lipolysis in hepatocytes is inhibited by ethanol exposure', Journal of Biological Chemistry, vol. 292, no. 28, pp. 11815-11828. https://doi.org/10.1074/jbc.M117.777748
Schott, Micah B. ; Rasineni, Karuna ; Weller, Shaun G. ; Schulze, Ryan J. ; Sletten, Arthur C. ; Casey, Carol A ; McNiven, Mark A. / β-adrenergic induction of lipolysis in hepatocytes is inhibited by ethanol exposure. In: Journal of Biological Chemistry. 2017 ; Vol. 292, No. 28. pp. 11815-11828.
@article{efbb9ecb31d647fcb8be3e5d4a1b8ea5,
title = "β-adrenergic induction of lipolysis in hepatocytes is inhibited by ethanol exposure",
abstract = "In liver steatosis (i.e. fatty liver), hepatocytes accumulate many large neutral lipid storage organelles known as lipid droplets (LDs). LDs are important in the maintenance of energy homeostasis, but the signaling mechanisms that stimulate LD metabolism in hepatocytes are poorly defined. In adipocytes, catecholamines target the β-adrenergic (β-AR)/cAMP pathway to activate cytosolic lipases and induce their recruitment to the LD surface. Therefore, the goal of this study was to determine whether hepatocytes, like adipocytes, also undergo cAMP-mediated lipolysis in response to β-AR stimulation. Using primary rat hepatocytes and human hepatoma cells, we found that treatment with the β-AR agent isoproterenol caused substantial LD loss via activation of cytosolic lipases adipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL). β-Adrenergic stimulation rapidly activated PKA, which led to the phosphorylation of ATGL and HSL and their recruitment to the LD surface. To test whether this β-AR-dependent lipolysis pathway was altered in a model of alcoholic fatty liver, primary hepatocytes from rats fed a 6-week EtOH-containing Lieber-DeCarli diet were treated with cAMP agonists. Compared with controls, EtOH-exposed hepatocytes showed a drastic inhibition in β-AR/cAMP-induced LD breakdown and the phosphorylation of PKA substrates, including HSL. This observation was supported in VA-13 cells, an EtOH-metabolizing human hepatoma cell line, which displayed marked defects in bothPKAactivation and isoproterenol-induced ATGL translocation to the LD periphery. In summary, these findings suggest that β-AR stimulation mobilizes cytosolic lipases for LD breakdown in hepatocytes, and perturbation of this pathway could be a major consequence of chronic EtOH insult leading to fatty liver.",
author = "Schott, {Micah B.} and Karuna Rasineni and Weller, {Shaun G.} and Schulze, {Ryan J.} and Sletten, {Arthur C.} and Casey, {Carol A} and McNiven, {Mark A.}",
year = "2017",
month = "7",
day = "14",
doi = "10.1074/jbc.M117.777748",
language = "English (US)",
volume = "292",
pages = "11815--11828",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "28",

}

TY - JOUR

T1 - β-adrenergic induction of lipolysis in hepatocytes is inhibited by ethanol exposure

AU - Schott, Micah B.

AU - Rasineni, Karuna

AU - Weller, Shaun G.

AU - Schulze, Ryan J.

AU - Sletten, Arthur C.

AU - Casey, Carol A

AU - McNiven, Mark A.

PY - 2017/7/14

Y1 - 2017/7/14

N2 - In liver steatosis (i.e. fatty liver), hepatocytes accumulate many large neutral lipid storage organelles known as lipid droplets (LDs). LDs are important in the maintenance of energy homeostasis, but the signaling mechanisms that stimulate LD metabolism in hepatocytes are poorly defined. In adipocytes, catecholamines target the β-adrenergic (β-AR)/cAMP pathway to activate cytosolic lipases and induce their recruitment to the LD surface. Therefore, the goal of this study was to determine whether hepatocytes, like adipocytes, also undergo cAMP-mediated lipolysis in response to β-AR stimulation. Using primary rat hepatocytes and human hepatoma cells, we found that treatment with the β-AR agent isoproterenol caused substantial LD loss via activation of cytosolic lipases adipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL). β-Adrenergic stimulation rapidly activated PKA, which led to the phosphorylation of ATGL and HSL and their recruitment to the LD surface. To test whether this β-AR-dependent lipolysis pathway was altered in a model of alcoholic fatty liver, primary hepatocytes from rats fed a 6-week EtOH-containing Lieber-DeCarli diet were treated with cAMP agonists. Compared with controls, EtOH-exposed hepatocytes showed a drastic inhibition in β-AR/cAMP-induced LD breakdown and the phosphorylation of PKA substrates, including HSL. This observation was supported in VA-13 cells, an EtOH-metabolizing human hepatoma cell line, which displayed marked defects in bothPKAactivation and isoproterenol-induced ATGL translocation to the LD periphery. In summary, these findings suggest that β-AR stimulation mobilizes cytosolic lipases for LD breakdown in hepatocytes, and perturbation of this pathway could be a major consequence of chronic EtOH insult leading to fatty liver.

AB - In liver steatosis (i.e. fatty liver), hepatocytes accumulate many large neutral lipid storage organelles known as lipid droplets (LDs). LDs are important in the maintenance of energy homeostasis, but the signaling mechanisms that stimulate LD metabolism in hepatocytes are poorly defined. In adipocytes, catecholamines target the β-adrenergic (β-AR)/cAMP pathway to activate cytosolic lipases and induce their recruitment to the LD surface. Therefore, the goal of this study was to determine whether hepatocytes, like adipocytes, also undergo cAMP-mediated lipolysis in response to β-AR stimulation. Using primary rat hepatocytes and human hepatoma cells, we found that treatment with the β-AR agent isoproterenol caused substantial LD loss via activation of cytosolic lipases adipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL). β-Adrenergic stimulation rapidly activated PKA, which led to the phosphorylation of ATGL and HSL and their recruitment to the LD surface. To test whether this β-AR-dependent lipolysis pathway was altered in a model of alcoholic fatty liver, primary hepatocytes from rats fed a 6-week EtOH-containing Lieber-DeCarli diet were treated with cAMP agonists. Compared with controls, EtOH-exposed hepatocytes showed a drastic inhibition in β-AR/cAMP-induced LD breakdown and the phosphorylation of PKA substrates, including HSL. This observation was supported in VA-13 cells, an EtOH-metabolizing human hepatoma cell line, which displayed marked defects in bothPKAactivation and isoproterenol-induced ATGL translocation to the LD periphery. In summary, these findings suggest that β-AR stimulation mobilizes cytosolic lipases for LD breakdown in hepatocytes, and perturbation of this pathway could be a major consequence of chronic EtOH insult leading to fatty liver.

UR - http://www.scopus.com/inward/record.url?scp=85024386890&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024386890&partnerID=8YFLogxK

U2 - 10.1074/jbc.M117.777748

DO - 10.1074/jbc.M117.777748

M3 - Article

C2 - 28515323

AN - SCOPUS:85024386890

VL - 292

SP - 11815

EP - 11828

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 28

ER -